Suresh Senan

41.6k citations

468 papers · 22.7k indexed · 10 hit papers · h-index 74

Impact in

Radiation top 0.01%
- Advanced Radiotherapy Techniques
Pulmonary and Respiratory Medicine top 0.01%
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Radiation Therapy and Dosimetry

Papers in

Radiation 206
- Advanced Radiotherapy Techniques 206
Pulmonary and Respiratory Medicine 368
- Lung Cancer Diagnosis and Treatment 294
- Lung Cancer Treatments and Mutations 152
- Radiation Therapy and Dosimetry 45

Co-authors: Ben J. Slotman Frank J. Lagerwaard Cornelis J.A. Haasbeek David A. Palma Wilko F.A.R. Verbakel J.P. Cuijpers Solange Peters Keith M. Kerr
Journals: International Journal of Radiation Oncology*Biology*Physics (133 papers)Radiotherapy and Oncology (65 papers)Journal of Thoracic Oncology (36 papers)Lung Cancer (34 papers)Annals of Oncology (22 papers)
Partner nations: Netherlands United States Canada

In The Last Decade

Suresh Senan

448 papers receiving 22.3k citations

Hit Papers

10 papers align trajectories log scale

Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer 2017 · 247 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Radiotherapy and Oncology
2017 Annals of Oncology
2016 Annals of Oncology
2014 The Lancet
2013 International Journal of Radiation Oncology*Biology*Physics
2013 Annals of Oncology
2011 The Lancet Oncology
2009 International Journal of Radiation Oncology*Biology*Physics
2008 International Journal of Radiation Oncology*Biology*Physics
2007 New England Journal of Medicine

Peers

Countries citing papers authored by Suresh Senan

Since Specialization

Citations

This map shows the geographic impact of Suresh Senan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Senan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Senan more than expected).

Fields of papers citing papers by Suresh Senan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh Senan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Senan. The network helps show where Suresh Senan may publish in the future.

Co-authors

The 25 scholars most cited alongside Suresh Senan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suresh Senan Line = papers co-authored together Suresh Senan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study Journal for ImmunoTherapy of Cancer ·Idris Bahce, Chris Dickhoff, Famke L. Schneiders, Joris D. Veltman, David J. Heineman, Sayed M.S. Hashemi, Anne Vrijmoet, Ilias Houda, Ezgi B Ulas, Joyce Bakker, Peter M. van de Ven, N. Bouwhuis, Lilian J. Meijboom, Daniela E. Oprea‐Lager, Febe van Maldegem, Marieke F. Fransen, Tanja D. de Gruijl, Teodora Radonic, Suresh Senan	2024	5
2	MA17.04 Patient-Reported Outcomes (PROs) With Consolidation Durvalumab Versus Placebo Following cCRT in Limited-Stage SCLC: ADRIATIC Journal of Thoracic Oncology ·Samantha Novello, Ying Cheng, David R. Spigel, Jian Fang, Yuanbin Chen, Yoshitaka Zenke, Ki Hyeong Lee, Alejandro Navarro, E.L. Buchmeier, J.W.-C. Chang, Isamu Okamoto, Mustafa Özgüroğlu, Y.J. Kim, Nguyễn Thị Thái Hòa, Sayed M.S. Hashemi, Robert Turner, Helen Mann, Y.S. Olivo, Haiyi Jiang, Suresh Senan	2024	1
3	Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases Clinical and Translational Radiation Oncology ·Gamze Uğurluer, Famke L. Schneiders, Stefanie Corradini, Luca Boldrini, Rupesh Kotecha, Patrick Kelly, Lorraine Portelance, Philip Camilleri, Merav Ben‐David, Spencer Poiset, Sebastian Marschner, Giulia Panza, Tuğçe Kütük, Miguel A. Palacios, Alessandra Castelluccia, Teuta Zoto Mustafayev, Banu Atalar, Suresh Senan, Enis Özyar	2024	3
4	New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe The Lancet Regional Health - Europe ·Ilias Houda, Chris Dickhoff, Carin A. Uyl‐de Groot, Noemı́ Reguart, Mariano Provencio, Antonin Lévy, Rafał Dziadziuszko, Cecilia Pompili, Massimo Di Maïo, Michael L. Thomas, Alessandro Brunelli, Sanjay Popat, Suresh Senan, Idris Bahce	2024	18
5	Challenges and controversies in resectable non-small cell lung cancer: a clinician’s perspective The Lancet Regional Health - Europe ·Ilias Houda, Chris Dickhoff, Carin A. Uyl‐de Groot, Ronald Damhuis, Noemı́ Reguart, Mariano Provencio, Antonin Lévy, Rafał Dziadziuszko, Cecilia Pompili, Massimo Di Maïo, Michael Thomas, Alessandro Brunelli, Sanjay Popat, Suresh Senan, Idris Bahce	2024	17
6	First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET Journal for ImmunoTherapy of Cancer ·Johanna E. E. Pouw, Sayed M.S. Hashemi, Marc C. Huisman, Jessica E. Wijngaarden, Maarten Slebe, Daniela E. Oprea‐Lager, Gerben J.C. Zwezerijnen, Daniëlle J. Vugts, Ezgi B Ulas, Tanja D. de Gruijl, Teodora Radonic, Suresh Senan, C. Willemien Menke‐van der Houven van Oordt, Idris Bahce	2024	3
7	Accuracy of deformable image registration-based intra-fraction motion management in Magnetic Resonance-guided radiotherapy Physics and Imaging in Radiation Oncology ·M. Palacios, G. Gerganov, Paul Cobussen, S. Tetar, Tobias Finazzi, Ben J. Slotman, Suresh Senan, Cornelis J.A. Haasbeek, I. Kawrakow	2023	8
8	The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma Radiotherapy and Oncology ·M. Duijm, Esther Oomen‐de Hoop, N. van Voort van der Zyp, Paul van de Vaart, H. Tekatli, Mischa S. Hoogeman, Suresh Senan, Joost J. Nuyttens	2021	9
9	Changes in gastric anatomy after delivery of breath-hold MR-guided SABR for adrenal metastases Radiotherapy and Oncology ·John R. van Sörnsen de Koste, M. Palacios, Hanbo Chen, Famke L. Schneiders, A. Bruynzeel, Ben J. Slotman, Cornelis J.A. Haasbeek, Suresh Senan	2020	6
10	Country Report: The Report of Transplant Activity and Outcome During the First 12 Months at the First National Hematopoietic Stem Cell Transplant Center in Sri Lanka PubMed ·Prasad Abeysinghe, L. Morawaka, Sachini Gunasekara, Suresh Senan, Pwdcc Jayathilake, P. H. S. P. Udara, P. P. R. Siriwardena, Samuel T. Milliken, John J. Moore, Ddf Ma	2019	1
11	Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review International Journal of Radiation OncologyBiologyPhysics ·Hanbo Chen, Suresh Senan, Esther J. Nossent, Gabriel Boldt, Andrew Warner, David A. Palma, Alexander V. Louie	2017	104
12	肺癌のための高線量高精度放射線療法の計画と送達のためのCancer(EORTC)勧告の研究と治療のためのヨーロッパ組織【Powered by NICT】 Radiotherapy and Oncology ·De Ruysscher Dirk, Faivre-Finn Corinne, Moeller Ditte, Nestle Ursula, W Hurkmans Coen, Le Pechoux Cecile, Belderbos Jose, Guckenberger Matthias, Suresh Senan	2017	35
13	Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy (SABR) for Lung Cancer: Physician Performance Versus Radiomic Assessment International Journal of Radiation OncologyBiologyPhysics ·Sarah A. Mattonen, David A. Palma, Carol Johnson, Alexander V. Louie, Mark Landis, George Rodrigues, Ian Chan, Roya Etemad‐Rezai, Timothy Pok Chi Yeung, Suresh Senan, Aaron D. Ward	2016	1
14	Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer Beneficial?: A Multi-institutional Propensity-Score Matched Analysis International Journal of Radiation OncologyBiologyPhysics ·George Rodrigues, Suresh Senan, Cary Oberije, Kayoko Tsujino, T. Wiersma, Marta Moreno, Tae Hyun Kim, Lawrence B. Marks, Ramesh Rengan, Luigi De Petris, Sara Ramella, Kim De Ruyck, Núria Rodríguez, A. Warner, Jeffrey D. Bradley, David A. Palma	2014	2
15	Patterns of Disease Recurrence Following Either Stereotactic Ablative Radiation Therapy (SABR) or Lobectomy by Video-assisted Thoracoscopic Surgery (VATS) in Stage I-II Non-small Cell Lung Cancer: Outcomes of a Propensity Score-matched Analysis International Journal of Radiation OncologyBiologyPhysics ·Suresh Senan, N.E. Verstegen, David A. Palma, George Rodrigues, Frank J. Lagerwaard, A. van der Elst, R. Mollema, Allison Betof Warner, Ben J. Slotman, J. Wolter Oosterhuis	2012	1
16	Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – Can we distinguish recurrence from fibrosis? A systematic review of the literature Radiotherapy and Oncology ·Kitty Huang, Max Dahele, Suresh Senan, Matthias Gückenberger, George Rodrigues, Aaron D. Ward, Gabriel Boldt, David A. Palma	2012	156
17	The MARS feasibility trial: conclusions not supported by data reply Pure Amsterdam UMC ·Judith M. Bliss, Gill Coombes, Liz Darlison, John Edwards, James Entwisle, Lucy Kilburn, David Landau, Loı̈c Lang-Lazdunski, Mary Claire O’Brien, Kenneth J. O’Byrne, Julian Peto, Suresh Senan, M. Snee, James Spicer, Carol Tan, Gill Thomas, Tom Treasure, David Waller	2011	4
18	Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis Journal of Clinical Oncology ·David A. Palma, Otto Visser, Frank J. Lagerwaard, J. Belderbos, Ben J. Slotman, Suresh Senan	2010	347
19	Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups Journal of Clinical Oncology ·Ben J. Slotman, Murielle Mauer, Andrew Bottomley, Corinne Faivre‐Finn, G. Kramer, Elaine M. Rankin, M. Snee, M. Hatton, Pieter E. Postmus, Laurence Collette, Suresh Senan	2008	164
20	4D imaging for target definition in stereotactic radiotherapy for lung cancer Acta Oncologica ·Ben J. Slotman, Frank J. Lagerwaard, Suresh Senan	2006	54

About Suresh Senan

Suresh Senan is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 468 papers that have together received 22.7k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (294 papers), Advanced Radiotherapy Techniques (206 papers), Lung Cancer Treatments and Mutations (152 papers), Radiomics and Machine Learning in Medical Imaging (81 papers), Medical Imaging Techniques and Applications (80 papers), Lung Cancer Research Studies (64 papers), Radiation Therapy and Dosimetry (45 papers) and Head and Neck Cancer Studies (43 papers). The work is most often cited by research in Radiation (9.6k citations), Pulmonary and Respiratory Medicine (17.9k citations), Radiology, Nuclear Medicine and Imaging (8.5k citations), Otorhinolaryngology (1.6k citations) and Oncology (6.0k citations). Suresh Senan has collaborated with scholars based in Netherlands, United States and Canada. Frequent co-authors include Ben J. Slotman, Frank J. Lagerwaard, Cornelis J.A. Haasbeek, David A. Palma, Wilko F.A.R. Verbakel, J.P. Cuijpers, Solange Peters, Keith M. Kerr, Johan Vansteenkiste and Egbert F. Smit. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology, Journal of Thoracic Oncology, Lung Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact